Shannon Lea Harris

Title: Innovations by Shannon Lea Harris

Introduction

Shannon Lea Harris is an accomplished inventor based in Nanuet, NY (US). She holds a total of 9 patents, showcasing her significant contributions to the field of medical research and innovation. Her work primarily focuses on compositions and methods related to Neisseria meningitidis, a critical area in vaccine development.

Latest Patents

One of her latest patents involves a composition that includes a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. This invention is designed to elicit an immune response against both serogroup B strains and non-serogroup B strains. The compositions and methods described are intended for administration in humans, including adults, adolescents, toddlers, and infants. This innovative approach aims to enhance the effectiveness of vaccines against meningococcal diseases.

Career Highlights

Shannon is currently associated with Pfizer Corporation, a leading global biopharmaceutical company. Her role at Pfizer allows her to contribute to groundbreaking research and development in the field of immunology and vaccine technology. Her expertise and dedication have made her a valuable asset to the company and the scientific community.

Collaborations

Throughout her career, Shannon has collaborated with notable colleagues, including Annaliesa Sybil Anderson and Kathrin Ute Jansen. These collaborations have further enriched her research and have led to advancements in the understanding and treatment of infectious diseases.

Conclusion

Shannon Lea Harris exemplifies the spirit of innovation in the medical field through her patents and research contributions. Her work continues to impact public health positively, particularly in the development of effective vaccines.